GlassScriptPhysician profile
Scott Kyle Luttge
NPI 1821082272
$1,812.42
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2021: $11.85 · 2022: $233 · 2023: $945 · 2024: $63.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003 · Education: $5.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.52 |
| Education | $5.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $256.33 | 2023 | Provenge |
| Intuitive Surgical, INC. | $236.84 | 2019 | |
| Covidien LP | $162.62 | 2019 | |
| Sumitomo Pharma America, INC. | $143.26 | 2023 | Orgovyx, Gemtesa |
| Davol INC. | $143.04 | 2019-2023 | Arista Ah Flexitip |
| Urogen Pharma, INC. | $128.96 | 2023 | Jelmyto |
| Abbvie INC. | $87.97 | 2022-2023 | |
| Antares Pharma, INC. | $79.20 | 2022-2023 | Tlando, Xyosted, Nocdurna |
| Janssen Biotech, INC. | $60.02 | 2022-2023 | Erleada |
| Astrazeneca Pharmaceuticals LP | $52.83 | 2023 | Lynparza |
| Progenics Pharmaceuticals, INC. | $52.21 | 2022 | |
| Endo Pharmaceuticals INC. | $44.65 | 2019-2023 | Aveed, Xiaflex |
| Alnylam Pharmaceuticals INC. | $40.41 | 2022 | |
| Halozyme INC | $38.90 | 2023 | |
| Pfizer INC. | $38.46 | 2022-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $37.64 | 2022 | |
| Teleflex LLC | $33.09 | 2024 | Urolift |
| Verity Pharmaceuticals INC. | $30.20 | 2024 | Trelstar |
| 180 Medical, INC. | $26.64 | 2023 | Gentlecath Glide |
| Coloplast Corp | $25.11 | 2021-2023 | Speedicath |
| Sun Pharmaceutical Industries INC. | $23.32 | 2023 | Yonsa |
| Boston Scientific Corporation | $23.27 | 2019 | |
| Accord Healthcare, INC. | $17.40 | 2023 | |
| Myriad Genetic Laboratories, INC. | $15.70 | 2023 | Prolaris |
| C. R. Bard, INC. & Subsidiaries | $14.35 | 2023 | Bard Urinary Drainage Bag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Luttge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.